Roivant President, Immunovant CEO Eric Venker sells USD 6.99 million in common shares

Reuters2026/07/30 01:00

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Roivant Sciences President and Immunovant CEO Eric Venker sold 200,000 common shares on July 27 at a weighted average USD 34.95.
He exercised options for 200,000 shares the same day at USD 3.85.
Directly held common shares fell to 1,613,063.
Directly held stock options rose to 4,044,834.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Roivant Sciences Ltd. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-26-030107), on July 29, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Recently, Meta launched its personal AI agent product, Muse AI, marking the transition of consumer artificial intelligence from Q&A-based chatbots to an era of intelligent agents capable of independently completing real-world tasks. Goldman Sachs released a research report maintaining a “Buy” rating on Meta.

智通财经•2026/09/14 07:16